Old Web
English
Sign In
Acemap
>
authorDetail
>
Hirotaka Nakayama
Hirotaka Nakayama
Yokohama City University Medical Center
Medicine
Cancer research
Thyroid
Lenvatinib
VEGF receptors
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tyrosine kinase inhibitor (TKI) treatment outcome of stage IV-C thyroid differentiated cancer (analyzed by lesion evaluation)
2018
Hiroyuki Iwasaki
Haruhiko Yamazaki
Nobuyasu Suganuma
Yuko Sugawara
Naoki Gotoh
Shinsuke Hatori
Hirotaka Nakayama
Katsuhiko Masudo
Show All
Source
Cite
Save
Citations (0)
Expression of VEGFR2 and clinical response of anaplastic thyroid cancer to lenvatinib
2018
Haruhiko Yamazaki
Hiroyuki Iwasaki
Nobuyasu Suganuma
Tomoyuki Yokose
Hiroyuki Hayashi
Sachie Osanai
Katsuhiko Masudo
Hirotaka Nakayama
Kaori Kohagura
Yasushi Rino
Munetaka Masuda
Show All
Source
Cite
Save
Citations (0)
Clinical outcome by AMES risk definition in Japanese differentiated thyroid carcinoma patients.
2007
Asian Journal of Surgery
Nobuyuki Wada
Shinichi Hasegawa
Yoshihiko Masudo
Shohei Hirakawa
Kenichi Matsuzu
Nobuyasu Suganuma
Hirotaka Nakayama
Yasushi Rino
Toshio Imada
Show All
Source
Cite
Save
Citations (4)
1